Skip to content

Effect and safety analysis of Sotn ureteroscopic lithotripsy with NTrap and flexible ureteroscopic lithotripsy in the treatment of upper ureteral calculi

Effect and safety analysis of Sotn ureteroscopic lithotripsy with NTrap and flexible ureteroscopic lithotripsy in the treatment of upper ureteral calculi

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091762
Enrollment
Unknown
Registered
2024-11-03
Start date
2024-11-10
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper ureteral calculi

Interventions

Experimental group:Sotn ureteroscopic lithotripsy with NTrap
Control group:flexible ureteroscopic lithotripsy

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18-80 years old; 2. Diagnosed as upper ureteral calculi; 3. The surgical methods selected are Sotn ureteroscopic lithotripsy with NTrap and flexible ureteroscopic lithotripsy 4. Patients who do not have severe urinary tract infections before surgery or whose infections have been controlled, and whose urine cultures are positive, are treated with sensitive antibiotics for anti infection treatment (converted to negative before surgery); 5. All patients underwent surgical treatment for unilateral stones.

Exclusion criteria

Exclusion criteria: 1. Individuals with severe heart and respiratory diseases who cannot tolerate surgery. 2. Unregulated systemic hemorrhagic disease. 3. Patients with severe spinal deformities, hip joint deformities, and excessive obesity who cannot undergo lithotomy surgery. 4. Patients with a history of renal anatomical abnormalities, ureteral stenosis, congenital urinary system abnormalities, tuberculosis, or tumors on the affected side in the past; 5. Patient data is incomplete.

Design outcomes

Primary

MeasureTime frame
Stone-free rate;

Secondary

MeasureTime frame
Operative time;Hospital costs;Clavien-Dindo classification;Postoperative hospital stay;

Countries

China

Contacts

Public ContactWang Kefeng

Shengjing Hospital of China Medical University

fqy_2008@126.com+86 189 4025 4849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026